REPLIVEL

View On IC.GC.CA

REGISTERED

on 8 Feb 2011

Last Applicant/ Owned by

Sunesis Pharmaceuticals, Inc.

suite 400395 Oyster Point BoulevardSouth San Francisco, CA 94080

Serial Number

1352696 filed on 21^st Jun 2007

Registration Number

TMA789991 registered on 8^th Feb 2011

Registration expiry Date

8^th Feb 2026

Correspondent Address

GOWLING WLG (CANADA) LLP

SUITE 16001 FIRST CANADIAN PLACE100 KING STREET WESTTORONTO

ONTARIO

M5X1G5

REPLIVEL

Trademark usage description

pharmaceutical preparations for the treatment of tumors and cancer.

Classification Information

CIPO Classification Code

Nice

1352696

Trademark

Action Taken	Status
Submitted for opposition 12 on 15^th Sept 2009	Extension of Time
Submitted for opposition 12 on 12^th Mar 2009	Extension of Time
Submitted for opposition 12 on 30^th Sept 2008	Extension of Time
Submitted for opposition 12 on 15^th Apr 2008	Extension of Time
Submitted for opposition 22 on 28^th Nov 2007	Search Recorded
Submitted for opposition 20 on 28^th Nov 2007	Examiner's First Report
Submitted for opposition 15 on 26^th Sept 2007	Correspondence Created
Submitted for opposition 31 on 28^th Jun 2007	Formalized
Submitted for opposition 1 on 22^nd Jun 2007	Created
Submitted for opposition 30 on 21^st Jun 2007	Filed